|
Mr. Kennard joined Halozyme in 2004 and brings to Halozyme nearly 30 years of professional senior management experience in the fields of regulatory affairs (RA) clinical programs and quality assurance (QA). He has worked directly with the U.S. Food and Drug Administration (FDA) as well as regulatory authorities of various foreign ministries of health to secure registration authorize commercialization and successfully implement quality programs for a broad range and extensive number of product approvals across pharmaceuticals biologics medical devices and diagnostics. Prior to Halozyme Mr. Kennard was Vice President of Worldwide RA/QA at Quidel Inc. a manufacturer of diagnostic products where he led the RA/QA and Clinical functions while also establishing a Quality System CE marking program that enabled Quidel to expand and sustain sales in the European Union. From 1991 to 2001 he was Vice President of RA/QA/R&D for Nobel Biocare Inc. and Steri-Oss (acquired by Nobel Biocare) where he directed all regulatory affairs quality assurance clinical trials and R&D activities. From 1981 to 1991 Mr. Kennard was Director of RA/QA at Allergan Inc. where he directed regulatory affairs quality assurance and quality control in the development and manufacture of prescription and OTC ophthalmic and dermatological drugs injectable drugs biotechnology products and ophthalmic products. Prior to Allergan he was Director of Quality Control at B. Braun. Mr. Kennard holds a BS degree in Microbiology. | 